Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

THE EFFECTS OF SINGLE DOSES OF 6-DIMETHYLAMINO-4-4-DIPHENYL-3-HEPTANONE (AMIDONE, METHADON, OR ‘10820’) ON HUMAN SUBJECTS

Harris Isbell, Anna J. Eisenman, Abraham Wikler and Karl Frank
Journal of Pharmacology and Experimental Therapeutics January 1948, 92 (1) 83-89;
Harris Isbell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna J. Eisenman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abraham Wikler
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karl Frank
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

1. 5.0 mgm. subcutaneous doses of amidone elevated the pain threshold of non-addicts and former morphine addicts as much as 10-15 mgm. of morphine sulfate.

2. Respiratory rate, pulse rate, rectal temperature and systolic blood pressures were lowered by amidone.

3. 10-30 mgm. doses of amidone subcutaneously had no significant effect on the electrocardiogram.

4. 60-75 mgm. of amidone in divided doses had no significant effect on the blood sugar of former addicts.

5. 30-75 mgm. of amidone always produced sedation in former morphine addicts. The electroencephalographic pattern was sometimes shifted to the slow side after 30-mgm. doses.

6. 30 mgm., or more, of amidone subcutaneously regularly produced euphoria in former morphine addicts; 10-30 mgm. doses intravenously induced intense euphoria. Narcotic drug addicts would abuse amidone if it were freely available.

Footnotes

    • Received September 19, 1947.

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 92, Issue 1
1 Jan 1948
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
THE EFFECTS OF SINGLE DOSES OF 6-DIMETHYLAMINO-4-4-DIPHENYL-3-HEPTANONE (AMIDONE, METHADON, OR ‘10820’) ON HUMAN SUBJECTS
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

THE EFFECTS OF SINGLE DOSES OF 6-DIMETHYLAMINO-4-4-DIPHENYL-3-HEPTANONE (AMIDONE, METHADON, OR ‘10820’) ON HUMAN SUBJECTS

Harris Isbell, Anna J. Eisenman, Abraham Wikler and Karl Frank
Journal of Pharmacology and Experimental Therapeutics January 1, 1948, 92 (1) 83-89;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

THE EFFECTS OF SINGLE DOSES OF 6-DIMETHYLAMINO-4-4-DIPHENYL-3-HEPTANONE (AMIDONE, METHADON, OR ‘10820’) ON HUMAN SUBJECTS

Harris Isbell, Anna J. Eisenman, Abraham Wikler and Karl Frank
Journal of Pharmacology and Experimental Therapeutics January 1, 1948, 92 (1) 83-89;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

Article

  • PST3093 Stimulates SERCA2a and Improves Cardiac Function
  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Tissue Selectivity of Antidiabetic Agent Nateglinide: Study on Cardiovascular and β-Cell KATP Channels
Show more Article

Articles

  • PST3093 Stimulates SERCA2a and Improves Cardiac Function
  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Tissue Selectivity of Antidiabetic Agent Nateglinide: Study on Cardiovascular and β-Cell KATP Channels
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics